Literature DB >> 21666734

Perspective: miles to go before we sleep.

Charles Rice1.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 21666734     DOI: 10.1038/474S8a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  4 in total

1.  Inhibition of hepatitis C virus NS5B polymerase by S-trityl-L-cysteine derivatives.

Authors:  Daniel B Nichols; Guy Fournet; K R Gurukumar; Amartya Basu; Jin-Ching Lee; Naoya Sakamoto; Frank Kozielski; Ira Musmuca; Benoît Joseph; Rino Ragno; Neerja Kaushik-Basu
Journal:  Eur J Med Chem       Date:  2012-01-12       Impact factor: 6.514

2.  The crystal structure of NS5A domain 1 from genotype 1a reveals new clues to the mechanism of action for dimeric HCV inhibitors.

Authors:  Sebastian M Lambert; David R Langley; James A Garnett; Richard Angell; Katy Hedgethorne; Nicholas A Meanwell; Steve J Matthews
Journal:  Protein Sci       Date:  2014-04-05       Impact factor: 6.725

3.  2-Heteroarylimino-5-arylidene-4-thiazolidinones as a new class of non-nucleoside inhibitors of HCV NS5B polymerase.

Authors:  Ilkay Küçükgüzel; Gökhan Satılmış; K R Gurukumar; Amartya Basu; Esra Tatar; Daniel B Nichols; Tanaji T Talele; Neerja Kaushik-Basu
Journal:  Eur J Med Chem       Date:  2013-09-12       Impact factor: 6.514

4.  Discovery of new scaffolds for rational design of HCV NS5B polymerase inhibitors.

Authors:  Andriy G Golub; K R Gurukumar; Amartya Basu; Volodymyr G Bdzhola; Yaroslav Bilokin; Sergiy M Yarmoluk; Jin-Ching Lee; Tanaji T Talele; Daniel B Nichols; Neerja Kaushik-Basu
Journal:  Eur J Med Chem       Date:  2012-09-17       Impact factor: 6.514

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.